Congenital Heart Defect Leads to Transplant
Growing up, Jason Ewen always knew his heart was a little different. He could participate in most activities, like camping, ﬁshing and hunting. But when it came to sports, Ewen knew he’d have to stay on the sidelines.
“I could not run one lap around the track. I had to walk,” says Ewen, who was born with a type of congenital heart disease (CHD) known as transposition of the great arteries, which required three open-heart surgeries before his second birthday.
Fifty years ago, babies born with serious heart abnormalities rarely lived past childhood. Today, thanks to advances in diagnostic strategies and surgical techniques, Ewen, now 43, is one of roughly 1.5 million adults in the U.S. with CHD, and he’s among one of the fastest-growing patient populations in the country.
“Technology, experience and history are helping us move forward at a rapid pace,” explains Stacy Fisher, MD, a University of Maryland Medical Center cardiologist who focuses on adult congenital heart disease. “Even in my career, I’ve seen patients who were not treatable become treatable and get normal function back.”
Almost one in 100 children is born with an abnormally developed heart. Problems can include a hole in the heart, missing valves, underdeveloped chambers and everything in between. But with so many variations, treating adults with CHD can be a challenge because no two patients are alike.
What’s more, as the population of adults with CHD increases, the number of physicians trained to treat them must grow, too. But keeping up isn’t easy. Only 190 physicians in the U.S. are certiﬁed to treat adult congenital heart disease, two of whom practice medicine in the University of Maryland Medical System: Dr. Fisher and Geoffrey Rosenthal, MD, division chief of pediatric cardiology and co-director of the Children’s Heart Program at the University of Maryland Medical Center. So, for every board-certiﬁed adult congenital heart disease physician, there are more than 7,890 patients.
“That means adults with CHD either aren’t getting care at all or they’re getting care from providers who are less experienced in treating them,” notes Dr. Rosenthal, a professor of pediatrics at the University of Maryland School of Medicine.
A Strong Team
To become certiﬁed in adult congenital heart disease, physicians can take one of two paths: An adult cardiologist can do two years of pediatric cardiology training, or a pediatric cardiologist can do two years of adult cardiology training.
Dr. Fisher, who serves as an associate professor of medicine at the University of Maryland School of Medicine, comes from adult cardiology. Dr. Rosenthal trained as a pediatric cardiologist. Their different backgrounds enable them to provide patients with the best treatment possible.
“When there are complex issues, we can put our heads together and try to meet all the needs of both aspects of care,” says Dr. Fisher.
Dr. Rosenthal agrees and notes, “At the University of Maryland, not only do we have two people who are board-certiﬁed in adult congenital heart disease, but one of us specializes in adults, and the other in children. It’s a great partnership.”
A top-rate surgical team is necessary, too. Most congenital heart diseases require surgery early in life, often just days birth.
The high quality of care provided by the University of Maryland Medical Center’s comprehensive team of cardiovascular specialists is well documented, says Dr. Rosenthal. “We measure the outcomes of virtually everything that we do,” he says, “and our outcomes are very good, frequently outpacing national averages.”
A New Baby and a New Heart
When CHD patients reach adulthood, they may be faced with a variety of possible complications, such as heart rhythm problems, heart failure or the possibility of stroke. But it’s not only health issues that they have to manage. Insurance, employment and disability beneﬁts can also prove cumbersome.
Family planning is another big issue. Patients want to know if their child could have a heart defect, too.
Dr. Fisher says most congenital heart patients’ babies have about a 5 to 10 percent chance of having CHD, regardless of whether the mother or the father has CHD. At the University of Maryland Medical Center’s Fetal Heart Program, fetal ultrasound can show these defects at about 12 weeks of pregnancy.
For the ﬁrst 15 years of his marriage, Jason Ewen was skeptical about having kids because of his heart defect. Aside from physical limitations, he had a relatively normal childhood. But in his early 20s, Ewen began experiencing complications.
That’s when Ewen was diagnosed with atrial ﬁbrillation, a rapid heart rate that causes poor blood ﬂow. His was 180 beats per minute. (A normal heart rate is 60 to 100 beats per minute.) A procedure known as cardioversion and new medications helped him regain a normal rate.
In 2006, Ewen’s heart stopped while he was in the emergency room, and he had to be resuscitated. A deﬁbrillator was implanted, new medications were prescribed, and checkups became very regular.
But talk of the transplant coincided with another surprise: Ewen and his wife, Ellen, were going to have a baby. A fetal heart screening showed that their child did not have a heart defect. Two weeks after his son Banner-Wolf’s birth, Ewen was moved up the transplant list.
Two months later, Ewen received the call that there was a match: the University of Maryland Medical Center had a heart for his transplant.
Now, Ewen is doing what he couldn’t do his whole life: jogging more than a mile while training for a 5K.
“If you have a heart disease or condition, don’t let it stop you and hold up your life from doing what you enjoy,” Ewen says. “If you can do it, enjoy it, because you don’t know what tomorrow’s going to bring.”